Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 674,812 | 692,624 | 613,328 | 411,261 | 741,970 |
| Cost of Goods | 18,215 | 14,600 | N/A | N/A | N/A |
| Gross Profit | 656,597 | 678,024 | 613,328 | 411,261 | 741,970 |
| Operating Expenses | 416,568 | 427,942 | 394,616 | 348,290 | 358,915 |
| Operating Income | 240,244 | 250,682 | 218,712 | 62,972 | 383,055 |
| Interest Expense | 65,625 | 5,986 | 2,484 | 62,684 | -12,117 |
| Other Income | -43,561 | 149,796 | 35,502 | 40,924 | -289,934 |
| Pre-tax Income | 131,058 | 394,492 | 251,730 | 41,213 | 105,238 |
| Income Tax | 40,805 | 83,658 | 53,473 | 8,646 | 13,202 |
| Net Income Continuous | 90,252 | 310,834 | 198,258 | 32,567 | 92,036 |
| Net Income | $90,252 | $310,834 | $198,258 | $32,567 | $92,036 |
| EPS Basic Total Ops | 1.38 | 4.76 | 3.04 | 0.50 | 1.41 |
| EPS Basic Continuous Ops | 1.38 | 4.76 | 3.04 | 0.50 | 1.41 |
| EPS Diluted Total Ops | 1.36 | 4.72 | 3.01 | 0.49 | 1.38 |
| EPS Diluted Continuous Ops | 1.36 | 4.72 | 3.01 | 0.49 | 1.38 |
| EBITDA(a) | $240,244 | $250,682 | $218,712 | $62,972 | $383,055 |